## VRNS: Varonis Systems, Inc. - XLK: Technology

### Executive Summary

No thesis match: MRS_10 2.8% below STRENGTH zone (3.0-6.0%); PEG 6.84 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($31.76)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 3
- **Sentiment:** Bearish (Bullish: 0, Bearish: 2)

**1. VARONIS SYSTEMS Is Being Investigated for Potential Securities Law Violations - Contact Kaplan Fox & Kilsheimer LLP**
- Source: FinancialContent | 20251220T073000 | Bearish | Relevance: 100%
- Kaplan Fox & Kilsheimer LLP is investigating Varonis Systems, Inc. (NASDAQ: VRNS) for potential securities law violations after the company missed its Q3 2025 revenue forecast and reported a significant decline in term license subscription revenues. This news led to a substantial drop in Varonis's stock price, prompting investors who suffered losses to contact the law firm.

**2. VARONIS SYSTEMS Is Being Investigated for Potential Securities Law Violations - Contact Kaplan Fox & Kilsheimer LLP**
- Source: NewMediaWire | 20251220T073000 | Bearish | Relevance: 100%
- Kaplan Fox & Kilsheimer LLP is investigating potential securities law violations against Varonis Systems, Inc. (NASDAQ: VRNS) after the company announced third-quarter 2025 financial results that missed forecasts and reported a significant decline in term license subscription revenues. Following this news, Varonis's stock price fell significantly, leading to the investigation. Investors who suffered losses are encouraged to contact Kaplan Fox.

**3. Squarepoint Ops LLC Decreases Position in Varonis Systems, Inc. $VRNS**
- Source: MarketBeat | 20251220T100845 | Neutral | Relevance: 100%
- Squarepoint Ops LLC drastically reduced its stake in Varonis Systems (NASDAQ:VRNS) by 96.1% in Q2, selling 797,569 shares and retaining 32,000 shares valued at $1.624 million. Despite this, other institutions like State of Wyoming and Tower Research Capital LLC TRC significantly increased their holdings, showcasing varied institutional sentiment. Varonis recently reported quarterly EPS of $0.06, in line with estimates, and revenue of $161.6 million, slightly below expectations, while maintaining a consensus "Moderate Buy" rating with a target price of $59.79.

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 38.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 6 |

**Top Holders:**
- Vanguard Group Inc: 10.7% (+3.6%)
- Blackrock Inc.: 9.0% (-6.9%)
- Voya Investment Mana: 2.8% (-0.4%)
- First Trust Advisors: 2.7% (+7.9%)
- Goldman Sachs Group : 2.5% (-22.0%)

### Key Risks

1. Valuation stretched: PEG 6.8x requires aggressive growth execution.
2. Long-term trend broken: trading 27.6% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 6.84 signals overvaluation risk, limited margin of safety. Forward P/E 102.7x attractive for 164% earnings growth. Institutional flow bullish (4 buying vs 6 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $4.1B |
| Beta | 0.64 |
| 52W Range | $30.02 - $63.90 |
| Short Interest | 5.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 6.84 |
| Forward P/E | 102.7 |
| Current P/E | 271.2 |
| YoY Growth | 164.2% |
| EPS Direction | RISING |

### Technicals

MRS_10 deteriorating from 4.0% to 2.8% (-1.2% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 0.2pp (needs >3.0% for momentum thesis). MRS_5 at 1.7% confirms short-term momentum alignment. Below SMA200 (0.72x), long-term trend not supportive. MACD histogram positive (0.83), confirming momentum. RSI neutral at 49. OFD pattern: +MTL (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 2.81% (CS: 89) | Neutral |
| RSI_14 | 49.2 | Neutral |
| MACD Histogram | 0.83 | Bullish |
| vs SMA20 | 1.059x | Above |
| vs SMA50 | 0.860x | Below |
| vs SMA200 | 0.724x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $34.44
- **Stop Loss:** $31.76 (7.8% risk)
- **Target:** $37.12 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 447
- **Position Value:** $15,394.68
- **Portfolio %:** 15.39%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 120% | L2 100% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with improving risk appetite. VIX decline to 52-week lows and moderate breadth recovery suggest calming conditions, though narrow participation indicates selectivity remains key. Positive earnings momentum and AI adoption themes provide fundamental support for quality growth names.*

### Earnings

**Next:** 2026-02-03 (Est: $0.03)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.05 | $0.06 | +11.0% |
| 2025Q2 | $0.01 | $0.03 | +273.1% |
| 2025Q1 | $-0.05 | $0.01 | +120.8% |
| 2024Q4 | $0.14 | $0.18 | +27.3% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*